Cargando…
The Clinical Value of PET with Amino Acid Tracers for Gliomas WHO Grade II
The clinical management of adults with low-grade gliomas (LGGs) remains a challenge. There is no curative treatment, and management of individual patients is a matter of deciding optimal timing as well as right treatment modality. In addition to conventional imaging techniques, positron emission tom...
Autores principales: | Smits, Anja, Baumert, Brigitta G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094834/ https://www.ncbi.nlm.nih.gov/pubmed/21603237 http://dx.doi.org/10.1155/2011/372509 |
Ejemplares similares
-
Amino acid tracers in PET imaging of diffuse low-grade gliomas: a systematic review of preoperative applications
por: Näslund, Olivia, et al.
Publicado: (2018) -
A Comparison of PET Tracers in Recurrent High-Grade Gliomas: A Systematic Review
por: Muthukumar, Sankar, et al.
Publicado: (2022) -
WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade Gliomas
por: Carstam, Louise, et al.
Publicado: (2022) -
The clinical value of proneural, classical and mesenchymal protein signatures in WHO 2021 adult-type diffuse lower-grade gliomas
por: Dénes, Anna, et al.
Publicado: (2023) -
PROX1 is a predictor of survival for gliomas WHO grade II
por: Elsir, T, et al.
Publicado: (2011)